FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1656162023> ?p ?o ?g. }

• W1656162023 endingPage "2515" @default.
• W1656162023 startingPage "2508" @default.
• W1656162023 abstract "Peroxisome proliferator-activated receptors (PPAR) are members of a nuclear hormone receptor superfamily that includes receptors for steroids, retinoids, and thyroid hormone, all of which are known to affect the immune response. Previous studies dealing with PPAR-gamma expression in the immune system have been limited. Recently, PPAR-gamma was identified in monocyte/macrophage cells. In this study we examined the role of PPAR-gamma in experimental autoimmune encephalomyelitis (EAE), an animal model for the human disease multiple sclerosis. The hypothesis we are testing is whether PPAR-gamma plays an important role in EAE pathogenesis and whether PPAR-gamma ligands can inhibit the clinical expression of EAE. Initial studies have shown that the presence of the PPAR-gamma ligand 15-deoxy-Delta(12,14)-PGJ(2) (15d-PGJ2) inhibits the proliferation of Ag-specific T cells from the spleen of myelin basic protein Ac(1-11) TCR-transgenic mice. 15d-PGJ2 suppressed IFN-gamma, IL-10, and IL-4 production by both Con A- and myelin basic protein Ac(1-11) peptide-stimulated lymphocytes as determined by ELISA and ELISPOT assay. Culture of encephalitogenic T cells with 15d-PGJ2 in the presence of Ag reduced the ability of these cells to adoptively transfer EAE. Examination of the target organ, the CNS, during the course of EAE revealed expression of PPAR-gamma in the spinal cord inflammatory infiltrate. Administration of 15d-PGJ2 before and at the onset of clinical signs of EAE significantly reduced the severity of disease. These results suggest that PPAR-gamma ligands may be a novel therapeutic agent for diseases such as multiple sclerosis." @default.
• W1656162023 created "2016-06-24" @default.
• W1656162023 creator A5021514185 @default.
• W1656162023 creator A5055938141 @default.
• W1656162023 creator A5061339912 @default.
• W1656162023 creator A5070237275 @default.
• W1656162023 creator A5075382753 @default.
• W1656162023 creator A5086308018 @default.
• W1656162023 creator A5088170616 @default.
• W1656162023 creator A5089538984 @default.
• W1656162023 date "2002-03-01" @default.
• W1656162023 modified "2023-09-25" @default.
• W1656162023 title "Peroxisome Proliferator-Activated Receptor-γ Agonist 15-Deoxy-Δ12,1412,14-Prostaglandin J2 Ameliorates Experimental Autoimmune Encephalomyelitis" @default.
• W1656162023 cites W1511195742 @default.
• W1656162023 cites W1539392991 @default.
• W1656162023 cites W1559792721 @default.
• W1656162023 cites W1608005125 @default.
• W1656162023 cites W1633340712 @default.
• W1656162023 cites W1639924204 @default.
• W1656162023 cites W1656968650 @default.
• W1656162023 cites W1979761686 @default.
• W1656162023 cites W1982476760 @default.
• W1656162023 cites W1984364811 @default.
• W1656162023 cites W1996267589 @default.
• W1656162023 cites W2002519246 @default.
• W1656162023 cites W2003066006 @default.
• W1656162023 cites W2003115027 @default.
• W1656162023 cites W2021758696 @default.
• W1656162023 cites W2023235828 @default.
• W1656162023 cites W2027193949 @default.
• W1656162023 cites W2029146247 @default.
• W1656162023 cites W2031694725 @default.
• W1656162023 cites W2036164613 @default.
• W1656162023 cites W2053242629 @default.
• W1656162023 cites W2063305853 @default.
• W1656162023 cites W2091321756 @default.
• W1656162023 cites W2095378845 @default.
• W1656162023 cites W2100640696 @default.
• W1656162023 cites W2103633745 @default.
• W1656162023 cites W2113279573 @default.
• W1656162023 cites W2114864434 @default.
• W1656162023 cites W2124371647 @default.
• W1656162023 cites W2138589755 @default.
• W1656162023 cites W2150557496 @default.
• W1656162023 cites W2150652688 @default.
• W1656162023 cites W2164015929 @default.
• W1656162023 cites W2168051361 @default.
• W1656162023 cites W2168332555 @default.
• W1656162023 cites W2172256092 @default.
• W1656162023 cites W4236818607 @default.
• W1656162023 doi "https://doi.org/10.4049/jimmunol.168.5.2508" @default.
• W1656162023 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11859145" @default.
• W1656162023 hasPublicationYear "2002" @default.
• W1656162023 type Work @default.
• W1656162023 sameAs 1656162023 @default.
• W1656162023 citedByCount "285" @default.
• W1656162023 countsByYear W16561620232012 @default.
• W1656162023 countsByYear W16561620232013 @default.
• W1656162023 countsByYear W16561620232014 @default.
• W1656162023 countsByYear W16561620232015 @default.
• W1656162023 countsByYear W16561620232016 @default.
• W1656162023 countsByYear W16561620232017 @default.
• W1656162023 countsByYear W16561620232018 @default.
• W1656162023 countsByYear W16561620232019 @default.
• W1656162023 countsByYear W16561620232020 @default.
• W1656162023 countsByYear W16561620232021 @default.
• W1656162023 countsByYear W16561620232022 @default.
• W1656162023 countsByYear W16561620232023 @default.
• W1656162023 crossrefType "journal-article" @default.
• W1656162023 hasAuthorship W1656162023A5021514185 @default.
• W1656162023 hasAuthorship W1656162023A5055938141 @default.
• W1656162023 hasAuthorship W1656162023A5061339912 @default.
• W1656162023 hasAuthorship W1656162023A5070237275 @default.
• W1656162023 hasAuthorship W1656162023A5075382753 @default.
• W1656162023 hasAuthorship W1656162023A5086308018 @default.
• W1656162023 hasAuthorship W1656162023A5088170616 @default.
• W1656162023 hasAuthorship W1656162023A5089538984 @default.
• W1656162023 hasBestOaLocation W16561620231 @default.
• W1656162023 hasConcept C126322002 @default.
• W1656162023 hasConcept C134018914 @default.
• W1656162023 hasConcept C170493617 @default.
• W1656162023 hasConcept C187345961 @default.
• W1656162023 hasConcept C203014093 @default.
• W1656162023 hasConcept C2778486448 @default.
• W1656162023 hasConcept C2778609137 @default.
• W1656162023 hasConcept C2779357208 @default.
• W1656162023 hasConcept C2780876595 @default.
• W1656162023 hasConcept C529278444 @default.
• W1656162023 hasConcept C71924100 @default.
• W1656162023 hasConcept C86803240 @default.
• W1656162023 hasConcept C8891405 @default.
• W1656162023 hasConceptScore W1656162023C126322002 @default.
• W1656162023 hasConceptScore W1656162023C134018914 @default.
• W1656162023 hasConceptScore W1656162023C170493617 @default.
• W1656162023 hasConceptScore W1656162023C187345961 @default.
• W1656162023 hasConceptScore W1656162023C203014093 @default.
• W1656162023 hasConceptScore W1656162023C2778486448 @default.
• W1656162023 hasConceptScore W1656162023C2778609137 @default.

• next